ArticleActa pharmacologica Sinica2020

The novel quinolizidine derivate IMB-HDC inhibits STAT5a phosphorylation at 694 and 780 and promotes DNA breakage and cell apoptosis via blocking STAT5a nuclear translocation.

Wu-Li Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.